Abstract
Emerging clinical evidence shows that the deregulation of ubiquitin-mediated degradation of oncogene products or tumour suppressors is likely to be involved in the aetiology of carcinomas and leukaemias. Recent studies have indicated that some members of the tripartite motif (TRIM) proteins (one of the subfamilies of the RING type E3 ubiquitin ligases) function as important regulators for carcinogenesis. This Review focuses on TRIM proteins that are involved in tumour development and progression.
Publication types
-
Research Support, Non-U.S. Gov't
MeSH terms
-
Animals
-
Autoantigens / metabolism
-
Carrier Proteins / genetics
-
Carrier Proteins / metabolism
-
Cell Transformation, Neoplastic / metabolism*
-
DNA-Binding Proteins / genetics
-
DNA-Binding Proteins / metabolism
-
Genes, p53 / genetics*
-
Humans
-
Minor Histocompatibility Antigens
-
Neoplasms / genetics
-
Neoplasms / metabolism*
-
Nuclear Proteins / genetics
-
Nuclear Proteins / metabolism
-
Prognosis
-
Promyelocytic Leukemia Protein
-
Repressor Proteins / genetics
-
Repressor Proteins / metabolism
-
Transcription Factors / genetics
-
Transcription Factors / metabolism
-
Translocation, Genetic
-
Tripartite Motif Proteins
-
Tripartite Motif-Containing Protein 28
-
Tumor Suppressor Proteins / genetics
-
Tumor Suppressor Proteins / metabolism
-
Ubiquitin-Protein Ligases / metabolism
-
Ubiquitination*
Substances
-
Autoantigens
-
Carrier Proteins
-
DNA-Binding Proteins
-
Minor Histocompatibility Antigens
-
Nuclear Proteins
-
Promyelocytic Leukemia Protein
-
Repressor Proteins
-
TRIM13 protein, human
-
TRIM22 protein, human
-
TRIM24 protein, human
-
TRIM29 protein, human
-
TRIM33 protein, human
-
Transcription Factors
-
Tripartite Motif Proteins
-
Tumor Suppressor Proteins
-
PML protein, human
-
TRIM28 protein, human
-
TRIM68 protein, human
-
Tripartite Motif-Containing Protein 28
-
Ubiquitin-Protein Ligases